Mars Group Holdings Corporation (TYO:6419)

Orchard Therapeutics Revenue

Mars Group Holdings had revenue of 8.68B JPY in the quarter ending June 30, 2025, a decrease of -36.02%. This brings the company's revenue in the last twelve months to 37.37B, down -10.56% year-over-year. In the fiscal year ending March 31, 2025, Mars Group Holdings had annual revenue of 42.25B with 15.52% growth.

• Revenue (ttm): 37.37B
• Revenue Growth: -10.56%
• P/S Ratio: 1.54
• Revenue / Employee: 59.31M
• Employees: 630
• Market Cap: 57.63B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	42.25B	5.68B	15.52%
Mar 31, 2024	36.58B	16.23B	79.77%
Mar 31, 2023	20.35B	5.24B	34.71%
Mar 31, 2022	15.10B	343.00M	2.32%
Mar 31, 2021	14.76B	-7.80B	-34.58%